Fagron Advanced Derma has been introduced in the first half of 2014. This innovative concept, which offers prescribers and pharmacists a total solution for treating patients with dermatological conditions, is already being used by dermatologists on three continents in their treatment plans. Fagron will be introducing six new Fagron Advanced Derma vehicles in September of this year. These new vehicles all comply with the schedule of requirements as defined for Fagron Advanced Derma. They are free of harmful and controversial ingredients and are all designed for maximum patient comfort. With this extension of the Fagron Advanced Derma vehicle line, Fagron Advanced Derma will become the total solution for dermatological compounding and basic skin care.
In the second half of 2014, Fagron’s R&D department will focus on developing a concept aimed at pain management which will be introduced worldwide in the first quarter of 2015. This total concept enables pharmacists and prescribers to offer patients individualised care in controlling pain. Central to this concept is innovative, non-systemic transdermal pharmaceutical compounding, which can provide very localised pain treatment. Non-systemic transdermal pharmaceutical compounding limits the side effects that frequently occur with the medication currently used, which is usually systemic.